EXTEDO Alternative: Why DnXT Is the Modern eCTD Publishing Choice

Why life sciences teams replace EXTEDO with DnXT. DnXT delivers cloud-native eCTD publishing, integrated validation, AI-powered classification, and 12-week implementations — without the legacy overhead of EXTEDO eCTDmanager.

The case for replacing EXTEDO eCTDmanager

EXTEDO eCTDmanager has been a fixture in regulatory publishing for over two decades. For many teams, it was the first dedicated eCTD tool they ever used — and it served them well during an era when on-premise software was the norm and regulatory submissions were handled by specialized departments working in isolation.

But the operating model for regulatory affairs has fundamentally changed. Teams are smaller, timelines are compressed, and the expectation is that publishing workflows integrate seamlessly with upstream document management and downstream submission tracking. Organizations evaluating an EXTEDO alternative aren’t doing so because the tool stopped working — they’re doing so because their needs have outgrown what legacy architecture can deliver. The overhead of maintaining Citrix environments, managing per-seat licenses, and manually validating outputs has become a drag on teams that need to move faster with fewer resources.

Modern regulatory operations demand cloud-native infrastructure, transparent pricing that scales with your portfolio rather than your headcount, and intelligent automation that reduces manual QC burden. For teams reconsidering their publishing stack, the question isn’t whether EXTEDO eCTDmanager still functions — it’s whether it positions you for the next decade of regulatory complexity.

5 reasons teams choose DnXT over EXTEDO eCTDmanager

1. Cloud-native architecture eliminates IT overhead

DnXT runs entirely on Microsoft Azure with a microservices architecture designed for regulatory workloads. There’s no Citrix environment to maintain, no server hardware to provision, and no dependency on internal IT for upgrades or patches. Your team accesses the platform through a browser, from anywhere, with enterprise-grade security and 21 CFR Part 11 compliance built in. For organizations searching for an EXTEDO alternative that removes infrastructure complexity, this shift alone can free up weeks of IT and validation time annually.

2. Transparent pricing that doesn’t penalize growth

Per-seat licensing models create a perverse incentive: the more people who need access to your publishing system, the more expensive it becomes. DnXT uses per-tenant pricing based on your submission volume and portfolio complexity — not headcount. This means you can onboard regulatory writers, QA reviewers, and project managers without renegotiating your contract. Teams that have moved from EXTEDO eCTDmanager consistently cite this pricing model as a deciding factor, particularly those scaling from a handful of programs to a broader pipeline.

3. AI-powered document classification reduces manual effort

DnXT’s classification engine uses a three-layer hybrid AI model to automatically identify document types, suggest eCTD placement, and flag anomalies before they reach validation. This isn’t a bolted-on feature — it’s integrated directly into the publishing workflow. For teams accustomed to manually classifying hundreds of documents per submission, the time savings are substantial. More importantly, the consistency reduces downstream validation failures and amendment cycles. Legacy tools like EXTEDO eCTDmanager were built before practical AI was available; retrofitting intelligence into that architecture is difficult and often incomplete.

4. Integrated validation catches errors earlier

DnXT’s validation engine runs both preflight and final checks against current FDA and EMA validation criteria, surfaced directly in the publishing interface. Errors are flagged in context, with specific guidance on remediation. This tight integration means issues are caught during assembly — not after a submission is already packaged. Teams evaluating an EXTEDO alternative often point to validation as a pain point: the manual, disconnected nature of legacy validation workflows creates unnecessary rework and delays. DnXT treats validation as a continuous process, not a final gate.

5. Faster implementation, faster time to value

A typical DnXT implementation takes 12 weeks from contract signature to production publishing. That includes configuration, validation protocol execution, user training, and parallel publishing to confirm output quality. Compare this to the 9-18 month timelines common with legacy RIM suites, and the operational impact becomes clear. Faster implementation means faster ROI — and less risk of organizational change derailing your project. For teams that need an EXTEDO alternative they can deploy within a single quarter, DnXT’s implementation model is built for that reality.

EXTEDO eCTDmanager vs DnXT: side-by-side

What migration from EXTEDO eCTDmanager to DnXT looks like

Switching publishing platforms is a significant operational decision, and teams rightly want to understand the process before committing. Migration from EXTEDO eCTDmanager to DnXT follows a structured approach designed to minimize disruption while ensuring full validation and compliance continuity.

The process begins with a discovery phase, typically lasting two weeks. During this period, DnXT’s implementation team works with your regulatory operations leads to understand your current submission portfolio, folder structures, naming conventions, and any custom workflows you’ve built around EXTEDO. This isn’t a generic questionnaire — it’s a hands-on assessment that shapes the configuration of your DnXT tenant. We also conduct a content audit to identify which historical submissions, if any, need to be migrated versus simply archived in your existing system.

The next phase involves parallel publishing: running your next planned submission through both EXTEDO eCTDmanager and DnXT simultaneously. This side-by-side comparison validates that DnXT produces compliant, equivalent output and gives your team hands-on experience before cutover. Parallel publishing typically spans four to six weeks, depending on your submission calendar. During this phase, we execute the validation protocol and complete all required documentation for your quality system.

Cutover happens once your team is confident in DnXT’s output and workflows. We provide role-based training tailored to publishers, reviewers, and administrators, ensuring each user understands the interface and their specific responsibilities. Post-cutover, DnXT’s customer success team remains engaged for the first 90 days, conducting check-ins and addressing any workflow refinements. The entire process — from kickoff to production — typically completes in 12 weeks. For teams that have experienced multi-year RIM implementations, this timeline often comes as a relief.

Frequently asked questions

How does DnXT pricing compare to EXTEDO eCTDmanager?

DnXT uses per-tenant pricing based on your submission volume and portfolio complexity, not the number of users accessing the system. This model typically results in significant savings for organizations with growing teams or those who need to provide access to reviewers, writers, and project managers beyond the core publishing group. We provide transparent pricing during the evaluation process — no negotiation games or hidden fees that emerge after contract signature.

Can we migrate historical submissions from EXTEDO to DnXT?

Yes, though the approach depends on your needs. Most organizations don’t require full migration of historical submission archives — those can remain in your existing document management or archival system. For active applications or lifecycle submissions that need continuity, DnXT can import the relevant eCTD structure and metadata to maintain a complete submission history. We scope migration requirements during the discovery phase and include the work in your implementation plan.

Is DnXT validated for 21 CFR Part 11 and Annex 11?

DnXT is designed for compliance with 21 CFR Part 11 and Annex 11 requirements. The platform includes native audit trails, electronic signature capabilities, role-based access controls, and data integrity protections. We provide validation documentation, including functional specifications and IQ/OQ protocols, as part of every implementation. Your quality team executes the validation protocol; we support them throughout the process and provide evidence packages for your quality system records.

How does DnXT integrate with our existing document management system?

DnXT provides modern REST APIs designed for integration with upstream document management systems, regulatory information management platforms, and clinical trial management systems. Common integration patterns include automated document ingestion from a DMS, metadata synchronization, and status updates pushed back to planning systems. During discovery, we assess your integration requirements and scope the work accordingly. For organizations searching for an EXTEDO alternative that fits into a broader technology ecosystem, integration flexibility is a core design principle.

What training and support does DnXT provide?

Every implementation includes role-based training for publishers, reviewers, and administrators. Training is conducted live by DnXT’s customer success team and tailored to your workflows and use cases — not generic recorded webinars. Post-implementation, all customers have access to our support team during business hours, with escalation paths for critical issues. We also provide ongoing enablement as new features are released, ensuring your team stays current without requiring revalidation for minor updates.